ALB and Sepsis: For example, in a propensity score-matched observational study of sepsis patients at increased risk because of cardiac comorbidity, the use of IV albumin was shown to be safe and the day 28 all-cause mortality was significantly reduced in the albumin-receiving group, but the day 90 all-cause and cardiac mortality were not; baseline levels of serum albumin (mean ± standard deviation) in the albumin and control groups were 29.4 ± 5.7 and 29.9 ± 4.6 g/L, respectively [33].